Hostname: page-component-745bb68f8f-b6zl4 Total loading time: 0 Render date: 2025-02-06T08:45:55.795Z Has data issue: false hasContentIssue false

Ovine toxoplasmosis

Published online by Cambridge University Press:  08 December 2009

ELISABETH A. INNES*
Affiliation:
Moredun Research Institute, Pentlands Science Park, Edinburgh EH26 OPZ
PAUL M. BARTLEY
Affiliation:
Moredun Research Institute, Pentlands Science Park, Edinburgh EH26 OPZ
DAVID BUXTON
Affiliation:
Moredun Research Institute, Pentlands Science Park, Edinburgh EH26 OPZ
FRANK KATZER
Affiliation:
Moredun Research Institute, Pentlands Science Park, Edinburgh EH26 OPZ
*
Corresponding author: E-mail: lee.innes@moredun.ac.uk
Rights & Permissions [Opens in a new window]

Summary

Congenital infection with Toxoplasma gondii is an important cause of abortion in sheep worldwide. The cat is the definitive host of the parasite, and infected cats may shed millions of oocysts in their faeces resulting in extensive environmental contamination and an important source of infection for grazing herbivorous animals. Studies looking at development of specific antibodies in sheep, as an indicator of exposure to T. gondii, have shown that there is an increase in seroprevalence associated with age indicating that most infections in sheep occur following birth. The stage of gestation when transplacental transmission of T. gondii to the developing foetus occurs is critical in determining the clinical outcome. The importance of endogenous transplacental transmission in persistently infected ewes and its clinical importance is a subject of current debate. Ewes infected prior to mating develop immune responses that help protect against disease in a subsequent pregnancy and also against experimental challenge administered during pregnancy. Both innate and adaptive immune responses are activated following T. gondii infection and experiments involving the chronic cannulation of peripheral lymph nodes in sheep have allowed the dynamics of the immune responses to be analysed in real time. A live vaccine, Toxovax® is the only commercially available vaccine worldwide to protect against congenital toxoplasmosis.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2009

Introduction

The protozoan parasite Toxoplasma gondii is a major cause of infectious ovine abortion in both UK and worldwide. Current data from the Veterinary Investigation Diagnosis Analysis (VIDA) in UK shows that the three pathogens most commonly diagnosed as causing abortion in sheep are Chlamydophila abortus (40%), Toxoplasma gondii (24%) and Campylobacter (14%), (www.defra.gov.uk/vla/reports). The national sheep flock is estimated to be in the region of 32 million animals and although the incidence of ovine toxoplasmosis is difficult to define, a study by Blewett and Trees (Reference Blewett and Trees1987) suggested that T. gondii may be responsible for 1–2% of neonatal losses annually. These losses would translate to over 0·5 million lambs in UK and 1·5 million lambs lost in Europe per year, representing a significant loss to producers and national economies. In this paper we discuss the history of the disease, parasite transmission routes, disease pathogenesis, host immunity and control strategies for ovine toxoplasmosis.

History and Background

Toxoplasma gondii is a fascinating parasite, discovered one hundred years ago by two different groups of scientists working in Tunisia (Nicolle and Manceaux, Reference Nicolle and Manceaux1908) and in Brazil (Splendore, Reference Splendore1908). The parasite was named based on its morphology, toxo meaning arc or bow and plasma meaning life and the original host animal it was discovered in, a hamster like rodent, the gundi, Ctenodactylus gundii. Since its discovery, Toxoplasma has been found to infect all warm blooded animals including humans making it arguably the most successful parasite worldwide (Ferguson, Reference Ferguson2009). Toxoplasma was first reported to be an important pathogen in sheep in the 1950s with a series of reports from Bill Hartley and colleagues in New Zealand where they observed T. gondii organisms in placental tissue from aborting sheep and within foetal tissues (Hartley, Jebson and McFarlane, Reference Hartley, Jebson and McFarlane1954; Hartley and Marshall, Reference Hartley and Marshall1957). Following this initial description, there were other reports of a similar disease in sheep occurring in Australia, UK and Europe (Dubey and Beattie, Reference Dubey and Beattie1988). The route of transmission of the parasite to sheep was initially unclear as at this time the only two known routes of T. gondii transmission were via consumption of undercooked meat containing T. gondii tissue cysts or congenital transmission from mother to foetus (Innes, Reference Innes2010). As sheep are herbivores, it was suggested that there may be another, as yet undiscovered, common route of transmission.

Work in the 1960s showed that cats were able to shed an environmentally stable form of T. gondii in their faeces (Hutchison, Reference Hutchison1965). These eggs or oocysts were found to be stable in the environment and could remain infective for up to 18 months depending on climatic conditions. Favourable conditions for oocyst survival are temperate and moist, which may be why ovine toxoplasmosis is a problem in temperate countries such as UK, Northern Europe and New Zealand (Buxton and Rodger, Reference Buxton, Rodger and Aitken2008). Further work confirmed the cat as the definitive host of T. gondii (Frenkel, Dubey and Miller, Reference Frenkel, Dubey and Miller1970; Hutchison et al. Reference Hutchison, Dunachie, Sim and Work1970; Ferguson et al. Reference Ferguson, Hutchison, Dunachie and Sim1974) and oocysts as a major source of environmental contamination and an important source of infection for grazing animals.

Transmission

Oocysts in the environment

Members of the cat family are the definitive hosts of the parasite and tend to become infected for the first time when they start hunting and eating wild rodents and birds already infected with T. gondii. Following consumption of T. gondii cysts, the parasites excyst in the gut of the cat and invade and infect host cells. Sexual development of the parasite takes place in the gut of the cat resulting in the production of oocysts which are shed in the faeces. Shedding usually occurs around 3–10 days after initial infection and may continue for 2–3 weeks (Dubey and Beattie, Reference Dubey and Beattie1988). During this period a cat may shed over 100 million oocysts and experimental studies in sheep have shown that a dose of only 200 oocysts may cause abortion in previously naïve pregnant sheep (McColgan, Buxton and Blewett, Reference McColgan, Buxton and Blewett1988). The importance of oocysts as a source of infection for sheep has been supported by studies showing an association with infection and contamination of feed or grazing land with sporulated oocysts (Plant, Richardson and Moyle, Reference Plant, Richardson and Moyle1974; Faull, Clarkson and Winter, Reference Faull, Clarkson and Winter1986), and also work showing an association with cats on farms and prevalence of T. gondii in sheep (Skjerve et al. Reference Skjerve, Waldeland, Nesbakken and Kapperud1998). Further studies looking at development of specific antibodies in sheep, as an indicator of exposure to T. gondii, have shown that there is an increase in seroprevalence associated with age. This indicates that there is extensive environmental contamination with T. gondii oocysts and that most infections in sheep occur following exposure to the parasite after birth (Waldeland, Reference Waldeland1977; Blewett, Reference Blewett1983; Lunden, Nasholm and Uggla, Reference Lunden, Nasholm and Uggla1994). Recent studies have indicated that there is widespread environmental contamination with T. gondii oocysts (Dabritz et al. Reference Dabritz, Miller, Atwill, Gardner, Leutenegger, Melli and Conrad2007).

Congenital transmission

Primary infection during pregnancy

As sheep are not carnivores, consumption of tissues infected with T. gondii bradyzoites contained within tissue cysts is not considered to be a route of transmission in these animals. The only other route of transmission is vertical from mother to foetus during pregnancy (Buxton and Rodger, Reference Buxton, Rodger and Aitken2008). The stage of pregnancy when transplacental transmission of T. gondii takes place is important in determining the clinical outcome. If infection occurs early in gestation, when the foetal immune system is relatively immature, foetal death is likely to occur. Infection at mid-gestation can result in birth of a stillborn or weak lamb which may have an accompanying small mummified foetus, whereas infection in later gestation may result in birth of a live, clinically normal, but infected lamb (Buxton, Reference Buxton1990). The birth of clinically normal but infected lambs usually occurs as a result of a primary infection in the third trimester of pregnancy, although it is also possible that transplacental transmission may occur as a result of recrudescence of an endogenous infection (Trees and Williams, Reference Trees and Williams2005).

Recrudescence of an endogenous infection

While recrudescence of a persistent endogenous infection is a very common route of congenital infection with the closely related parasite Neospora caninum in cattle (Innes et al. Reference Innes, Wright, Bartley, Maley, MacAldowie, Esteban-Redondo and Buxton2005; Williams et al. Reference Williams, Hartley, Bjorkman and Trees2009 – this special issue), it is not thought to be a significant route of transmission for T. gondii infection in sheep (Dubey and Beattie, Reference Dubey and Beattie1988; Buxton and Rodger, Reference Buxton, Rodger and Aitken2008).

However, recent studies, (Duncanson et al. Reference Duncanson, Terry, Smith and Hide2001; Williams et al. Reference Williams, Morley, Hughes, Duncanson, Terry, Smith and Hide2005, Morley et al. Reference Morley, Williams, Hughes, Terry, Duncanson, Smith and Hide2005, Reference Morley, Williams, Hughes, Thomasson, Terry, Duncanson, Smith and Hide2008), have suggested that endogenous transplacental transmission of T. gondii may be more important than was previously thought and that this route of transmission may be an important cause of lamb mortality. Data reported by Williams et al. (Reference Williams, Morley, Hughes, Duncanson, Terry, Smith and Hide2005) stated that 53·7% of lambs in their test flocks had evidence of congenital T. gondii infection at birth with 46% of live lambs and 90% of dead lambs being positive for T. gondii by PCR analysis. Further work that followed ewes over successive pregnancies reported a frequency of 21% for successive T. gondii positive abortions, suggesting that complete protective immunity has not been acquired following a previous infection (Morley et al. Reference Morley, Williams, Hughes, Thomasson, Terry, Duncanson, Smith and Hide2008).

These studies are very interesting although difficult to interpret with confidence as they rely heavily on PCR-based techniques and the methodology is not validated using supporting pathology, serological evidence or isolation of live parasites to show that the live lambs in the study were indeed congenitally infected with T. gondii as a result of endogenous transmission. In addition, the authors did not rule out other causes of abortion due to different pathogens on their study farm. These studies also raise the importance of the language we use to describe vertical transmission. To aid our understanding of this area it is important to define the difference between endogenous transplacental transmission and exogenous transplacental transmission as described by Trees and Williams (Reference Trees and Williams2005).

A recent relevant study in this area using a full range of different diagnostic techniques found that, in contrast to the studies described above, there was no significant transmission from persistently infected sheep to their offspring (Rodger et al. Reference Rodger, Maley, Wright, Mackellar, Wesley, Sales and Buxton2006). In this study, a group of sheep previously infected with T. gondii and a group of naïve control sheep were mated and followed through pregnancy to lambing. A full post-mortem was conducted on any dead lambs and placentas were examined using histopathological techniques and by T. gondii-specific PCR for evidence of infection. In addition, pre-colostral blood samples were collected from all the lambs to look for antibodies to T. gondii. The presence of T. gondii antibodies in pre-colostral blood samples is a good indicator that congenital transmission has occurred. The results showed that the group of 31 T. gondii-infected sheep gave birth to 43 live healthy lambs and 6 stillborn lambs. There was no evidence of T. gondii infection in any of the tissues examined using T. gondii-specific PCR and histopathological techniques, in addition all the foetal fluid samples from the dead lambs and the pre-colostral serum samples from the live lambs were sero-negative with the exception of one set of twin lambs born to one of the infected ewes. All the T. gondii-negative ewes produced live T. gondii-negative lambs. Therefore this more complete study using a variety of scientific techniques to confirm transmission and infection showed that the rate of congenital transmission from persistently infected ewes was very infrequent, around 3·2% (Rodger et al. Reference Rodger, Maley, Wright, Mackellar, Wesley, Sales and Buxton2006).

Data from previous published papers in this area also agree with the results of Rodger et al. that although endogenous transplacental transmission of T. gondii may occur it is very infrequent and does not pose a significant clinical risk. A study by Watson and Beverley in the UK showed that in a group of 26 ewes that were infected in a previous pregnancy with T. gondii and then retained and followed through a subsequent pregnancy gave birth to 24 live uninfected lambs with only one ewe aborting a pair of twins (Watson and Beverley, Reference Watson and Beverley1971). A larger study in Australia examined what proportion of lambs may be infected as a result of a re-activation of a previous infection and found that a group of 135 persistently infected ewes produced 178 live lambs all being pre-colostral antibody negative with evidence of only one of the ewes having an infected placenta. In addition, there was no evidence of T. gondii being isolated from their tissues using mouse inoculation. Therefore they concluded that congenital transmission of T. gondii from ewes persistently infected with the parasite is very infrequent (Munday, Reference Munday1972).

Oocysts are a Significant Source of infection for sheep and primary infection during Pregnancy poses a significant clinical risk

Taken together the studies reported by Rodger et al. (Reference Rodger, Maley, Wright, Mackellar, Wesley, Sales and Buxton2006), Watson and Beverley (Reference Watson and Beverley1971) and Munday (Reference Munday1972) all conclude that, while endogenous transplacental transmission may occur in persistently infected ewes, it is infrequent and is unlikely to pose a significant clinical risk. Their studies used a variety of diagnostic methods including serology, histopathology, detection of T. gondii-specific DNA and isolation of live parasites from tissues using a mouse inoculation bioassay. These data, alongside the evidence of increased seroprevalence with age and increased seroprevalence of animals maintained in outdoor environments, suggest that the most significant route of T. gondii transmission for sheep is via T. gondii oocysts in the environment. Another very important factor in determining risk of clinical disease is the development of protective immunity in the host.

The Disease

The disease toxoplasmosis in sheep usually manifests following a primary infection of a pregnant ewe, resulting in placental invasion and transplacental infection of the foetus. Typical clinical signs are abortion and production of stillborn or weak lambs often along with a small, mummified foetus. Placental tissue from infected ewes may also show characteristic gross white spot lesions which are visible to the naked eye and are areas of necrosis in the tissue which will limit its effective function in supporting the pregnancy (Buxton, Reference Buxton1990). Sheep may become infected from the consumption of sporulated oocysts. Once ingested, the oocysts excyst in the small intestine, releasing sporozoites which quickly invade and multiply within the cells of the gut differentiating into tachyzoites. The tachyzoites can be found multiplying within mesenteric lymph node cells by day 4 following infection (Dubey, Reference Dubey1984). Toxoplasma is an obligate intracellular parasite and uses a process of endodyogeny to multiply within host cells (Ferguson, Reference Ferguson2009). The parasitized cells then rupture releasing tachyzoites that invade other host cells. A common clinical sign is an elevated temperature in the animal which is observed co-incident with the appearance of tachyzoites in the mesenteric lymph nodes and the fever may last for a further week, during which time tachyzoites may be detected in the circulation (Dubey and Sharma, Reference Dubey and Sharma1980; Wastling, Nicoll and Buxton, Reference Buxton1993). In the pregnant ewe, the tachyzoites find their way to the placenta where they invade and multiply within the maternal caruncular septa in the placentome and from there they invade the adjoining foetal trophoblast cells (Buxton and Finlayson, Reference Buxton and Finlayson1986). The immune system of the sheep is modulated during pregnancy in order to prevent rejection of the semi-allogeneic foetus. This manifests as a damping down of the pro-inflammatory immune responses such as interleukin 2 (IL-2) and interferon gamma (IFNγ) at the maternal-foetal interface (Innes and Vermeulen, Reference Innes and Vermeulen2006; Entrican and Wheelhouse, Reference Entrican and Wheelhouse2006). This change in the immune environment of the placenta provides a favourable location for the parasite to establish and multiply.

Stage of gestation

A significant factor in determining the severity of disease is the stage of gestation when infection occurs. The earlier in gestation that infection occurs the more severe the consequences for the foetus (Watson and Beverley, Reference Watson and Beverley1971; Hartley and Moyle, Reference Hartley and Moyle1974; Blewett, Miller and Buxton, Reference Blewett, Miller and Buxton1982). Infection of the placenta and foetus early in gestation is usually fatal for the foetus. Infection at mid-gestation may result in birth of a stillborn or weak lamb usually accompanied by a small mummified foetus. Infection in late gestation may result in birth of a clinically normal but infected lamb (Buxton and Rodger, Reference Buxton, Rodger and Aitken2008). Another important factor in determining severity of the disease is the ability of the foetus to mount an immune response against the parasite which increases along with foetal gestational age (Innes and Vermeulen, Reference Innes and Vermeulen2006). Infection of ewes prior to pregnancy did not result in disease during pregnancy and lambs were born healthy and uninfected (Hartley, Reference Hartley1961). Ewes infected prior to mating and then experimentally challenged during pregnancy produced over 90% live uninfected lambs, compared to a group of naïve ewes receiving the same challenge during pregnancy that produced only 28% live lambs (McColgan et al. Reference McColgan, Buxton and Blewett1988).

These experiments showed that disease mainly manifests in ewes that are infected for the first time during pregnancy and that disease severity is linked to gestational age of the foetus at the time of transplacental transmission. In addition, ewes infected in one pregnancy are unlikely to have infected lambs in subsequent pregnancies suggesting that it may be possible to immunise ewes prior to mating. Experimental infection of ewes prior to mating did indeed confer protection against a challenge administered during pregnancy suggesting that it may be possible to control the disease using vaccination.

Host Immune Responses

Following initial infection of the ewe, both the innate and adaptive immune responses work together to limit multiplication of the fast replicating tachyzoite stage (Innes and Vermeulen, Reference Innes and Vermeulen2006). Toxoplasma parasites are able to stimulate innate immune mechanisms directly upon entry into the host. This direct stimulation of macrophages results in production of interleukin 12 (IL-12) which directly stimulates natural killer (NK) cells to produce interferon gamma (IFNγ) (Gazzinelli et al. Reference Gazzinelli, Hieny, Wynn, Wolf and Sher1993). Interferon gamma is known to be important in inhibiting the intracellular multiplication of T. gondii and in addition will create the appropriate cytokine microenvironment for the priming of the adaptive immune response towards a Th-1 type pro-inflammatory immune response (Innes and Vermeulen, Reference Innes and Vermeulen2006). Studies in sheep using the technique of chronic lymphatic cannulation allowed the study of the development of a primary immune response to T. gondii in real time (Innes and Wastling, Reference Innes and Wastling1995). Interestingly, the first immune response detected within 48 hours of T. gondii inoculation was IFNγ (Innes et al. Reference Innes, Panton, Thomson, Maley and Buxton1995a). Previous in vitro studies had shown that ovine IFNγ could significantly inhibit the intracellular multiplication of T. gondii tachyzoites within sheep cells (Oura et al. Reference Oura, Innes, Wastling, Entrican and Panton1993). Four to five days after inoculation of T. gondii, lymphoblast cells responding to the infection were detected in the efferent lymph. Using phenotypic markers specific for ovine lymphocytes the experiment showed that initially the predominant lymphoblast population comprised CD4+ T cells (Innes et al. Reference Innes, Panton, Sanderson, Thomson, Wastling, Maley and Buxton1995b). At day 9–10 post-inoculation, the lymphoblast population peaked, when around 50% of the cells leaving the node were blasting cells (Buxton et al. Reference Buxton, Thomson, Maley, Wastling, Innes and Panton1994). At peak lymphoblast output the predominant population switched to CD8+ T cells and in vitro studies showed that these activated CD8+ T cells were able to inhibit multiplication of T. gondii infected autologous ovine target cells directly (Innes et al. Reference Innes, Panton, Sanderson, Thomson, Wastling, Maley and Buxton1995b). Following the peak lymphoblast response, the parasite was no longer detected in the efferent lymph indicating that the immune system of the sheep had successfully controlled the infection (Innes and Wastling, Reference Innes and Wastling1995). Specific antibodies to T. gondii were detected from day 10–12 after inoculation indicating that cell mediated immune responses involving, CD4+, CD8+ T cells and IFNγ are important in protective immunity and recovery from a primary infection and specific antibody may play more of a role in protection against a secondary infection (Innes and Vermeulen, Reference Innes and Vermeulen2006).

These results, taken together with the work published by Watson and Beverley (Reference Watson and Beverley1971), showing that ewes infected in one pregnancy are unlikely to have infected lambs in subsequent pregnancies, and research published by McColgan and colleagues (Reference McColgan, Buxton and Blewett1988), showing that experimental infection of ewes prior to mating did indeed confer protection against a challenge administered during pregnancy, suggest that it may be possible to control the disease using vaccination.

Vaccine Development

Researchers in New Zealand observed that an isolate of T. gondii they had recovered from an aborted lamb and maintained in the laboratory by repeated passage in mice, had lost the ability to differentiate into either bradyzoites or oocysts and had become an incomplete strain comprising the tachyzoite stage (O'Connell, Wilkins and Te Punga, Reference O'Connell, Wilkins and Te Punga1988). This isolate, known as the S48 strain would induce a temporary infection in sheep but did not persist in the animals as it had lost the ability to differentiate into bradyzoites (Buxton, Reference Buxton1993). Inoculation of this isolate into sheep prior to mating was found to afford protection against T. gondii-induced abortion during pregnancy (O'Connell et al. Reference O'Connell, Wilkins and Te Punga1988; Wilkins, O'Connell and Te Punga, Reference Wilkins, O'Connell and Te Punga1988; Buxton, Reference Buxton1993). As T. gondii is an obligate intracellular pathogen, this live attenuated parasite was able to induce protective cell mediated immune responses as it would undergo limited multiplication within host cells, thus allowing the appropriate processing and presentation of antigens to the immune system (Buxton and Innes, Reference Buxton and Innes1995). When sheep previously vaccinated with the S48 isolate are then challenged with live parasites, the parasite is prevented from spreading by the host immune response (Buxton et al. Reference Buxton, Thomson, Maley, Wastling, Innes and Panton1994). Extrapolating these experimental findings to the situation in the field would mean that when a vaccinated pregnant sheep ingests oocysts on pasture, the sporozoites released in the gut would invade host cells and enter the mesenteric lymph nodes where the primed immune system would significantly limit the spread of the parasite. The action of the primed immune response would prevent the parasite from reaching the placenta and causing disease of the foetus.

Duration of immunity

Additional experiments examined the duration of immunity and showed that sheep vaccinated with the S48 strain of T. gondii and kept indoors away from any external challenge for 18 months were still immune to a challenge administered after 18 months which caused abortions in a naïve control group of sheep (Buxton et al. Reference Buxton, Thomson, Maley, Wright and Bos1993). Therefore immunisation with a live, incomplete strain of T. gondii was highly effective in protecting sheep against congenital toxoplasmsosis and would provide long lasting immunity from a single shot.

First commercial vaccine protecting against congenital toxoplasmosis

The vaccine, Toxovax® produced by Intervet Schering-Plough Animal Health is available for sale in New Zealand, the UK and several other countries in Europe. It is advised to be administered prior to mating and has a meat and milk withdrawal period of six weeks following vaccination. As it is a live vaccine there are problems associated with a short shelf-life and care should be taken by those administering it as it is a zoonotic pathogen. The Toxovax® vaccine is the only commercially available vaccine against T. gondii, but it would not be suitable for use in people as it is live and there may be safety concerns (Innes and Vermeulen, Reference Innes and Vermeulen2006). Studies using killed vaccine preparations have not been successful in inducing protective immunity in sheep (Buxton et al. Reference Buxton, Uggla, Lovgren, Thomson, Lunden, Morein and Blewett1989), this may be because killed antigens are not inducing the relevant cell mediated immune responses known to be important in protective immunity (Innes and Vermeulen, Reference Innes and Vermeulen2006).

The S48 vaccine is highly effective in helping to prevent congenital toxoplasmosis in sheep by stimulating protective cell mediated immune responses prior to pregnancy. In addition, the immunity induced by the vaccine is long lasting in the absence of further challenge.

Concluding Remarks

Ovine toxoplasmosis is a significant cause of foetal loss in sheep worldwide. The weight of evidence from published scientific literature supports the theory that sporulated oocysts spread by cats into the environment are the most significant source of infection for sheep. Sheep show an increased likelihood of being seropositive to the parasite associated with age suggesting that postnatal acquisition of infection is an important route of transmission in sheep. While endogenous transplacental transmission may occur in persistently infected ewes it is infrequent and is unlikely to pose a significant clinical risk.

The work of Hide et al. (Reference Hide, Morley, Hughes, Gerwash, Elmahaishi, Elmahaishi, Thomasson, Wright, Williams, Murphy and Smith2009 – in this special issue) makes a contradictory case that endogenous transplacental transmission in persistently infected ewes is a significant route of T. gondii transmission and that this route does pose a significant clinical risk. While we know that endogenous transplacental transmission is very important in the epidemiology of bovine neosporosis, it is not thought to be as important in ovine toxoplasmosis. An issue with the studies by Hide et al. is that they rely heavily on PCR-based evidence to draw their conclusions and they do not verify their data using other techniques such as serology, histopathogy and isolation of live parasites. In addition, they do not investigate the role of other abortifacient agents that may be present on their study farms. Therefore, while their results do pose interesting questions that certainly warrant further research, the authors do need to further validate their findings using other standard and readily available diagnostic techniques to prove that endogenous transplacental transmission is taking place with the significant frequency they describe and show that that this represents a major clinical risk.

Our research and that of others has shown that sheep develop cell-mediated and humoral immune responses following infection with T. gondii that will protect against disease in a subsequent pregnancy. This protective immunity involves both the innate and adaptive immune responses in particular, CD4+, CD8+ T cells and IFNγ. As a result of sheep being able to mount effective protective immunity following infection, a live attenuated vaccine has been developed that provides effective and long-lasting protection against congenital toxoplasmosis.

Our understanding of ovine toxoplasmosis is such that we can advise farmers that a major disease risk for sheep involves naïve pregnant animals undergoing a primary infection following consumption of sporulated oocysts present in the environment. As there is known to be widespread environmental contamination with oocysts (Dabritz et al. Reference Dabritz, Miller, Atwill, Gardner, Leutenegger, Melli and Conrad2007), the best protection for sheep reared outdoors is for them to develop protective immunity against the parasite prior to mating. Vaccination is an effective way to help control ovine toxoplasmosis, along with good management of feed and water to prevent contamination with oocysts spread by cats.

We understand that there are still important areas of research to pursue such as whether some sheep may have a particular genetic susceptibility to T. gondii, understanding the immunological mechanisms involved in recrudescence of a persistent infection or whether some strains of the parasite may be more virulent than others. However, we feel it is important to validate new findings before advising farmers to adopt new practices in the management of their sheep flocks.

ACKNOWLEDGEMENTS

The authors would like to acknowledge the support of the Rural and Environmental Research Analysis Directorate of the Scottish Government.

References

Blewett, D. A. (1983). The epidemiology of ovine toxoplasmosis I. The interpretation of data for the prevalence of antibody in sheep and other host species. British Veterinary Journal 139, 537545.CrossRefGoogle ScholarPubMed
Blewett, D. A., Miller, J. K. and Buxton, D. (1982). Response of immune and susceptible ewes to infection with Toxoplasma gondii. Veterinary Record 111, 175178.CrossRefGoogle ScholarPubMed
Blewett, D. A. and Trees, A. J. (1987). The epidemiology of ovine toxoplasmosis with special respect to control. British Veterinary Journal 143, 128135.CrossRefGoogle Scholar
Buxton, D. (1990). Ovine toxoplasmosis: a review. Journal of the Royal Society of Medicine 83, 509511.CrossRefGoogle ScholarPubMed
Buxton, D. (1993). Toxoplasmosis: the first commercial vaccine. Parasitology Today 9, 335337.CrossRefGoogle ScholarPubMed
Buxton, D. and Finlayson, J. (1986). Experimental infection of pregnant sheep with Toxoplasma gondii: pathological and immunological observations on the placenta and foetus. Journal of Comparative Pathology 96, 319333.CrossRefGoogle ScholarPubMed
Buxton, D. and Innes, E. A. (1995). A commercial vaccine for ovine toxoplasmosis. Parasitology 110, 1116.CrossRefGoogle ScholarPubMed
Buxton, D. and Rodger, S. M. (2008). Toxoplasmosis and neosporosis. In Diseases of Sheep. 4th Ed (ed. Aitken, I. D.) Wiley-Blackwell, Hoboken, p. 112118.Google Scholar
Buxton, D., Thomson, K. M., Maley, S., Wastling, J. M., Innes, E. A. and Panton, W. R. M. (1994). Primary and secondary responses of the ovine lymph node to Toxoplasma gondii: cell output in efferent lymph and parasite detection. Journal of Comparative Pathology 111, 231241.Google Scholar
Buxton, D., Thomson, K. M., Maley, S., Wright, S. and Bos, H. J. (1993). Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine. Veterinary Record 133, 310312.CrossRefGoogle ScholarPubMed
Buxton, D., Uggla, A., Lovgren, K., Thomson, K., Lunden, A., Morein, B. and Blewett, D. A. (1989). Trial of a novel experimental Toxoplasma iscom vaccine in pregnant sheep. British Veterinary Journal 145, 451457.CrossRefGoogle ScholarPubMed
Dabritz, H. A., Miller, M. A., Atwill, E. R., Gardner, I. A., Leutenegger, C. M., Melli, A. C. and Conrad, P. A. (2007). Detection of Toxoplasma gondii like oocysts in cat faeces and estimates of the environmental oocyst burden. Journal of the American Veterinary Medical Association 231, 16761684.Google Scholar
Dubey, J. P. (1984). Experimental toxoplasmosis in sheep fed Toxoplasma gondii oocysts. International Goat and Sheep Research 2, 93104.Google Scholar
Dubey, J. P. and Beattie, C. P. (1988). Toxoplasmosis of Animals and Man. Boca Raton, Florida: CRC Press.Google Scholar
Dubey, J. P. and Sharma, S. P. (1980). Parasitaemia and tissue infection in sheep fed Toxoplasma gondii oocysts. Journal of Parasitology 66, 111114.CrossRefGoogle ScholarPubMed
Duncanson, P., Terry, R. S., Smith, J. E. and Hide, G. (2001). High levels of congenital transmission of Toxoplasma gondii in a commercial sheep flock. International Journal for Parasitology 31, 16991703.CrossRefGoogle Scholar
Entrican, G. and Wheelhouse, N. M. (2006). Immunity in the female sheep reproductive tract. Veterinary Research 37, 295309.CrossRefGoogle ScholarPubMed
Faull, W. B., Clarkson, M. J. and Winter, A. C. (1986). Toxoplasmosis in a flock of sheep: some investigations into its source and control. Veterinary Record 119, 491493.CrossRefGoogle Scholar
Ferguson, D. J. P. (2009). Toxoplasma gondii: 1908–2008, homage to Nicolle, Manceaux and Splendore. Memorias do Instituto Oswaldo Cruz 104, 133148.CrossRefGoogle ScholarPubMed
Ferguson, D. J. P., Hutchison, W. M., Dunachie, J. F. and Sim, J. C. (1974). Ultrastructural study of early stages of asexual multiplication and microgametogony of Toxoplasma gondii in the small intestine of the cat. Acta Pathology Microbiology Scandinavian Microbiology and Immunology 82, 167181.Google Scholar
Frenkel, J. K., Dubey, J. P. and Miller, N. L. (1970). Toxoplasma gondii in cats: faecal stages identified as coccidian oocysts. Science 167, 893896.CrossRefGoogle ScholarPubMed
Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S. and Sher, A. (1993). Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell deficient hosts. Proceedings of the National Academy of Sciences, USA 90, 61156119.CrossRefGoogle ScholarPubMed
Hartley, W. J. (1961). Experimental transmission of toxoplasmosis in sheep. New Zealand Veterinary Journal 9, 17.CrossRefGoogle Scholar
Hartley, W. J., Jebson, J. L. and McFarlane, D. (1954). New Zealand type II abortions in ewes. Australian Veterinary Journal 30, 216218.CrossRefGoogle Scholar
Hartley, W. J. and Marshall, S. C. (1957). Toxoplasmosis as a cause of ovine perinatal mortality. New Zealand Veterinary Journal 5, 119124.CrossRefGoogle Scholar
Hartley, W. J. and Moyle, G. G. (1974). Further observations on the epidemiology of ovine toxoplasma infection. Australian Journal of Experimental Biology and Medical Science 52, 647653.CrossRefGoogle ScholarPubMed
Hide, G., Morley, E. K., Hughes, J. M., Gerwash, O., Elmahaishi, M. S., Elmahaishi, K. H., Thomasson, D., Wright, E. A., Williams, R. H., Murphy, R. G. and Smith, J. E. (2009). Evidence for high levels of vertical transmission in Toxoplamsa gondii. Parasitology 136, 18771885.Google Scholar
Hutchison, W. M. (1965). Experimental transmission of Toxoplasma gondii. Nature 206, 961962.CrossRefGoogle ScholarPubMed
Hutchison, W. M., Dunachie, J. F., Sim, J. C. and Work, K. (1970). Coccidian-like nature of Toxoplasma gondii. British Medical Journal 1, 142144.Google Scholar
Innes, E. A. (2010). A brief history and overview of Toxoplasma gondii. Zoonoses and Public Health (In Press).CrossRefGoogle ScholarPubMed
Innes, E. A., Panton, W. R., Sanderson, A., Thomson, K. M., Wastling, J. M., Maley, S. W. and Buxton, D. (1995 b). Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function. Parasite Immunology 17, 151160.CrossRefGoogle ScholarPubMed
Innes, E. A., Panton, W. R., Thomson, K. M., Maley, S. and Buxton, D. (1995 a). Kinetics of interferon gamma production in vivo during infection with the S48 vaccine strain of Toxoplasma gondii. Journal of Comparative Pathology 113, 8994.CrossRefGoogle ScholarPubMed
Innes, E. A. and Vermeulen, A. N. (2006). Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133, 145168.CrossRefGoogle ScholarPubMed
Innes, E. A. and Wastling, J. M. (1995). Analysis of in vivo immune responses during Toxoplasma gondii infection using the technique of lymphatic cannulation. Parasitology Today 11, 268271.Google Scholar
Innes, E. A., Wright, S. E., Bartley, P., Maley, S., MacAldowie, C., Esteban-Redondo, I. and Buxton, D. (2005). The host-parasite relationship in bovine neosporosis. Veterinary Immunology and Immunopathology 108, 2936.CrossRefGoogle ScholarPubMed
Lunden, A., Nasholm, A. and Uggla, A. (1994). Long-term study of Toxoplasma gondii infection in a Swedish sheep flock. Acta Veterinary Scandinavia 35, 273281.CrossRefGoogle Scholar
McColgan, C., Buxton, D. and Blewett, D. (1988). Titration of Toxoplasma gondii oocysts in non-pregnant sheep and the effects of subsequent challenge during pregnancy. Veterinary Record 123, 467470.CrossRefGoogle ScholarPubMed
Morley, E. K., Williams, R. H., Hughes, J. M., Terry, R. S., Duncanson, P., Smith, R. S. and Hide, G. (2005). Significant familial differnces in the frequency of abortion and Toxoplasma gondii infection within a flock of Charollais sheep. Parasitology 131, 181185.CrossRefGoogle Scholar
Morley, E. K., Williams, R. H., Hughes, J. M., Thomasson, D., Terry, R. S., Duncanson, P., Smith, J. E. and Hide, G. (2008). Evidence that primary infection of Charollais sheep with Toxoplasma gondii may not prevent foetal infection and abortion in subsequent lambings. Parasitology 135, 169173.CrossRefGoogle Scholar
Munday, B. L. (1972). Transmission of Toxoplasma infection from chronically infected ewes to their lambs. British Veterinary Journal 128, 7172.Google ScholarPubMed
Nicolle, C. and Manceaux, L. (1908). Sur une infection a corps de Leishman (ou organisms voisons) du gondii. Comptes Rendues. Academy of Sciences 147, 736.Google Scholar
O'Connell, E., Wilkins, M. F. and Te Punga, W. A. (1988). Toxoplasmosis in sheep. II. The ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii. New Zealand Veterinary Journal 36, 14.Google Scholar
Oura, C. A., Innes, E. A., Wastling, J. M., Entrican, G. and Panton, W. R. (1993). The inhibitory effect of ovine recombinant interferon-gamma on intracellular replication of Toxoplasma gondii. Parasite Immunology 15, 535538.CrossRefGoogle ScholarPubMed
Plant, J. W., Richardson, N. and Moyle, G. G. (1974). Toxoplasma infection and abortion in sheep associated with feeding of grain contaminated with cat faeces. Australian Veterinary Journal 50, 1921.CrossRefGoogle ScholarPubMed
Rodger, S. M., Maley, S. W., Wright, S. E., Mackellar, A., Wesley, F., Sales, J. and Buxton, D. (2006). Ovine toxoplasmosis; the role of endogenous transmission. Veterinary Record 159, 768772.Google Scholar
Skjerve, E., Waldeland, H., Nesbakken, T. and Kapperud, G. (1998). Risk factors for the presence of antibodies to Toxoplasma gondii in Norwegian slaughter lambs. Preventative Veterinary Medicine 35, 219227.CrossRefGoogle ScholarPubMed
Splendore, A. (1908). Un nuovo protozoa parassita deconigli incontrato nelle lesioni anatomiche d'une malattia che ricorda in molti punti il Kala–azar dell'uoma. Nota preliminare pel. Review of the Societie of Sciences Sao Paulo 3, 109112.Google Scholar
Trees, A. J. and Williams, D. J. L. (2005). Endogenous and exogenous transplacental infection in Neospora caninum and Toxoplasma gondii. Trends in Parasitology 21, 558651.CrossRefGoogle ScholarPubMed
Waldeland, H. (1977). Toxoplasmosis in sheep. Influence of various factors on the antibody contents. Acta Veterinaria Scandinavia 18, 237247.CrossRefGoogle ScholarPubMed
Wastling, J. M., Nicoll, S. and Buxton, D. (1993). Comparison of two gene amplification methods for the detection of Toxoplasma gondii in experimentally infected sheep. Journal of Medical Microbiology 38, 360565.CrossRefGoogle ScholarPubMed
Watson, W. A. and Beverley, J. K. A. (1971). Epizootics of toxoplasmosis causing ovine abortion. Veterinary Record 88, 120124.CrossRefGoogle ScholarPubMed
Wilkins, M. F., O'Connell, E. and Te Punga, W. A. (1988). Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following lamb losses and reduce congenital infection following experimental oral challenge. New Zealand Veterinary Journal 36, 8689.Google Scholar
Williams, D. J. L., Hartley, C. S., Bjorkman, C. and Trees, A. J. (2009). Endogenous and exogenous transplacental transmission of Neospora caninum – how the route of transmission impacts on epidemiology and control of disease. Parasitology 136, 18951900.Google Scholar
Williams, R. H., Morley, E. K., Hughes, J. M., Duncanson, P., Terry, R. S., Smith, J. E. and Hide, G. (2005). High levels of congenital transmission of Toxoplasma gondii in longitudinal and cross sectional studies on sheep farms provides evidence of vertical transmission in ovine hosts. Parasitology 130, 301307.CrossRefGoogle ScholarPubMed